Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Little Green Pharma Ltd

Healthcare AU LGP

0.105AUD
-(-%)

Last update at 2025-06-20T06:10:00Z

Day Range

0.100.11
LowHigh

52 Week Range

0.080.17
LowHigh

Fundamentals

  • Previous Close 0.10
  • Market Cap31.92M
  • Volume63199
  • P/E Ratio10.50
  • Dividend Yield-%
  • EBITDA-0.26400M
  • Revenue TTM36.86M
  • Revenue Per Share TTM0.12
  • Gross Profit TTM 24.96M
  • Diluted EPS TTM0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -8.55665M -18.05176M 24.60M -9.31544M -5.51813M
Minority interest - - - - -
Net income -9.20543M -18.28625M -4.35647M -8.27640M -5.51813M
Selling general administrative 4.66M 19.25M 3.52M 2.20M 5.11M
Selling and marketing expenses 3.51M - 2.11M 1.46M -
Gross profit 11.98M 3.38M 5.78M 1.15M 0.05M
Reconciled depreciation 2.98M - 0.69M 0.19M -
Ebit -7.62781M -22.36922M 24.70M -8.98807M -5.17087M
Ebitda -4.64332M - 25.38M -8.80183M -
Depreciation and amortization 2.98M - 0.69M 0.19M -
Non operating income net other - - - - -
Operating income -7.62781M -18.96087M 24.70M -8.98807M -5.43140M
Other operating expenses 32.98M - 11.90M 9.80M -
Interest expense 0.93M - 0.09M 0.33M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 1.44M 1.52M 0.04M 2.64M 0.35M
Net interest income -0.87992M - -0.05226M -0.28031M -
Extraordinary items -0.64878M -0.23449M 0.00000M - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 4.32M - 28.96M -1.03903M -
Total revenue 19.57M 10.53M 7.00M 2.20M 0.25M
Total operating expenses 25.39M - 10.67M 8.75M 5.42M
Cost of revenue 7.59M 7.15M 1.23M 1.05M 0.20M
Total other income expense net 2.75M - -0.09154M -0.32737M -0.34726M
Discontinued operations - -0.31265M -0.23449M -0.23449M -0.23449M
Net income from continuing ops -8.55665M - 24.60M -9.31544M -5.51813M
Net income applicable to common shares -9.20543M -24.38166M 24.60M -9.31544M -5.51813M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 86.29M 98.62M 95.95M 110.99M 16.40M
Intangible assets 3.46M 3.64M 0.67M 0.71M 0.62M
Earning assets - - - - -
Other current assets 1.59M 1.49M 1.00M 1.99M 0.01M
Total liab 9.03M 16.39M 20.47M 17.10M 4.11M
Total stockholder equity 77.26M 82.23M 75.48M 93.89M 12.30M
Deferred long term liab - 3.02M - - -
Other current liab - 0.06M 0.24M 3.27M 0.95M
Common stock - 101.18M 90.25M 86.20M 29.94M
Capital stock 101.93M 101.18M - 86.20M 29.94M
Retained earnings -32.23725M -24.08469M -14.87926M 5.80M -18.80853M
Other liab - - 0.02M - -
Good will - - - - -
Other assets - 3.41M 0.20M 0.83M 0.34M
Cash 4.97M 12.40M - 40.27M 4.27M
Cash and equivalents - 12.40M 20.09M 40.27M 4.27M
Total current liabilities 6.42M 11.04M 16.55M 15.89M 2.66M
Current deferred revenue - 1.07M - 11.37M -
Net debt - -0.53234M - -38.84869M -2.58845M
Short term debt - 6.56M 11.88M 0.20M 0.24M
Short long term debt 2.36M 6.46M - - -
Short long term debt total - 11.87M - 1.42M 1.69M
Other stockholder equity - - 0.10M 1.90M 1.16M
Property plant equipment - 63.41M 59.58M 55.41M 9.14M
Total current assets 21.47M 31.15M 35.45M 54.03M 6.30M
Long term investments 0.36M 0.43M - 0.83M 0.34M
Net tangible assets - 81.61M 74.80M 93.17M 11.68M
Short term investments - - - - -
Net receivables 2.63M 7.38M 5.60M 3.66M 0.63M
Long term debt 1.14M 5.28M 3.78M 0.00000M 0.00000M
Inventory 10.93M 8.91M 8.19M 7.25M 1.35M
Accounts payable 1.65M 3.36M 1.55M 1.04M 1.47M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 5.13M - 1.90M 1.16M
Additional paid in capital - - - - -
Common stock total equity - - - - 29.94M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 64.82M 67.47M - 56.96M 10.10M
Capital lease obligations 1.65M 0.12M - 1.42M 1.69M
Long term debt total - 5.31M 3.90M 1.22M 1.45M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -14.03105M - -12.73438M -7.08005M 1.50M
Change to liabilities - -0.62083M -0.34687M 0.05M 1.26M
Total cashflows from investing activities -14.03105M -10.21384M -12.73438M -7.08005M 1.03M
Net borrowings - 4.90M -0.24582M 8.77M 1.32M
Total cash from financing activities 13.03M 6.30M 53.87M 16.93M 1.32M
Change to operating activities - 0.81M -0.20342M 0.12M 0.28M
Net income -9.20543M -24.38166M 24.60M -9.31544M -5.51813M
Change in cash -7.68619M -26.91021M 36.00M 3.76M -0.96372M
Begin period cash flow 20.09M 40.27M 4.27M 0.51M -
End period cash flow 12.40M 20.09M 40.27M 4.27M 0.51M
Total cash from operating activities -6.94017M -22.89095M -5.14958M -6.04857M -3.32140M
Issuance of capital stock 10.11M - 56.35M 10.00M -
Depreciation 2.98M 1.31M 0.69M 0.19M 0.08M
Other cashflows from investing activities -9.10240M -0.25000M -0.50000M -0.26953M -0.26953M
Dividends paid 5.81M - 1.02M - -
Change to inventory - 0.93M -3.84356M -0.81607M -0.35113M
Change to account receivables - -2.32019M -2.41601M -0.54138M -0.08828M
Sale purchase of stock -0.83774M 1.05M -2.23820M -1.83918M 0.00000M
Other cashflows from financing activities 11.54M -1.11910M 1.79M -0.22803M -1.83918M
Change to netincome - 1.34M -23.62854M 4.08M 1.00M
Capital expenditures 4.93M 10.17M 1.06M 6.81M 0.37M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.01190M -0.89482M -6.80987M 1.41M 1.11M
Stock based compensation - - - - -
Other non cash items - - -25.28882M 9.32M -
Free cash flow -11.86882M - -6.21103M -12.85909M -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LGP
Little Green Pharma Ltd		 - -% 0.10 10.50 0.35 0.87 0.38 0.93 2.95
AFP
AFT Pharmaceuticals Ltd		 -0.05 2.08% 2.35 24.00 20.24 1.23 2.72 1.43 13.69
VLS
Vita Life Sciences Ltd		 0.02 0.91% 2.21 13.75 - 1.52 2.31 1.17 6.89
SNT
Syntara Limited		 -0.004 7.55% 0.05 - 20.45 11.36 5.01 6.32 -2.1607
MVP
Medical Developments International		 - -% 0.57 - 166.67 1.64 1.12 1.22 278.77

Reports Covered

Stock Research & News

View All

Profile

Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and Europe. The company offers medicinal cannabis oil, flower, and vaporiser products. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.

Little Green Pharma Ltd

PO Box 690, West Perth, WA, Australia, 6872

Key Executives

Name Title Year Born
Ms. Fleta Jennifer Solomon CEO & Director NA
Mr. Angus McDougall Caithness Exec. Director NA
Mr. Paul Long Chief Operating Officer NA
Mr. Alistair Warren B.A., L.L.B. Gen. Counsel & Company Sec. NA
Ms. Celia Young Head of Marketing NA
Ms. Gabriela Franz Head of Sales & Distribution EU NA
Dr. Leon Warne Head of Research & Innovation NA
Ms. Lina Sandberg Head of Quality NA
Ms. Melanie Pugliese Head of Engagment NA
Brian Westergaard Head of IT NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.